ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
ResMed (RMD) Tops Q2 EPS by 15c
January 28, 2021 4:06 PM ESTResMed (NYSE: RMD) reported Q2 EPS of $1.41, $0.15 better than the analyst estimate of $1.26. Revenue for the quarter came in at $800 million versus the consensus estimate of $783.18 million.
Our second-quarter results reflect continued solid performance and positive trends across our business resulting in top-line... More
